secwatch.observer — SEC 8-K summary
======================================

Issuer:     HeartSciences Inc. (HSCS)
CIK:        0001468492
Form:       8-K
Filed at:   2023-01-24T23:59:59+00:00
Accession:  0000950170-23-001100
Event type: debt
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Heart Test Labs amends loan; extends FRV note to Sep 2024, reduces 2023 debt payments by $1.2M
--------------------------------------------------------------------------------

- Amendment No. 4 to Loan and Security Agreement dated Jan 24, 2023 with lenders FRV and John Q. Adams.
- FRV note (original $500k) maturity extended to Sept 30, 2024; all principal and accrued interest due then.
- JQA note (original $500k): accrued interest from June 28, 2022 due Sept 30, 2023; principal and later interest due March 31, 2024.
- Company states amendment reduces 2023 debt and accrued interest repayment obligations by $1.2 million.
- Company also releases all claims against lenders under the agreement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1468492/000095017023001100/0000950170-23-001100-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1468492/000095017023001100/hscs-20230124.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-001100

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer